The emerging phenotype of long-term survivors with infantile Pompe disease-Reference-Cited by-同舟云学术

The emerging phenotype of long-term survivors with infantile Pompe disease

Published:2012-09 Issue:9 Volume:14 Page:800-810
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Prater Sean N.,Banugaria Suhrad G.,DeArmey Stephanie M.,Botha Eleanor G.,Stege Erin M.,Case Laura E.,Jones Harrison N.,Phornphutkul Chanika,Wang Raymond Y.,Young Sarah P.,Kishnani Priya S.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/gim201244.pdf

Reference39 articles.

1. Hirschhorn R, Reuser AJJ. Glycogen storage disease type II: acid a-glucosidase (acid maltase) deficiency. In: Valle D, Scriver CR (eds). Scriver’s OMMBID. The Online Metabolic & Molecular Bases Of Inherited Disease. McGraw-Hill: New York, 2009.

2. Language and speech function in children with infantile Pompe disease;Muller;J Pediatr Neurol,2009

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing clinical outcomes: The journey of twins with CRIM-negative infantile-onset Pompe disease on high-dose enzyme replacement therapy and immunomodulation;Molecular Genetics and Metabolism Reports;2024-12

2. Precision medicine in action for Pompe disease;Molecular Therapy - Nucleic Acids;2024-09

3. Acid α-glucosidase (GAA) activity and glycogen content in muscle biopsy specimens of patients with Pompe disease: A systematic review;Molecular Genetics and Metabolism Reports;2024-06

4. The Importance of Early Treatment of Inherited Neuromuscular Conditions;Journal of Neuromuscular Diseases;2024-03-05

5. Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease;Molecular Genetics and Metabolism;2024-02